An Effect Of Hormone Therapy On Breast Cancer – Part 2 of 3
In taking a appearance at the three studies again, Shapiro and his team reviewed whether the evidence satisfied criteria important to researchers, such as the strength of an association, taking into account other factors that could influence risk. Their conclusion: The demonstrate is not strong enough to say definitively that hormone therapy causes breast cancer. The study is published in the current issue of the Journal of Family Planning and Reproductive Health Care.
The imaginative conclusion drew mixed reactions from experts. In an editorial accompanying the study, Nick Panay, a consultant gynecologist at the Queen Charlotte’s and Chelsea Hospital in London, supported the conclusions of the unexplored analysis. “If there is a risk, the risk is small, and the benefits of HRT can be life-altering. It is vital that we keep this in perspective when counseling our patients”.
The hormone therapy in use today is tone down in dose than those used in the previous research. “In principle, we tend to start with lower doses than we used to and increase as required until full symptom relief has been achieved”. What is needed now is a clinical nuisance in which the hormone therapy in use today is compared with placebo, to evaluate the risks and benefits.